rFXIII (recombinant Factor XIII)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for rFXIII (recombinant Factor XIII), covering 2017-01-11 to 2017-01-11. Get the full timeline:
Most recent: Clinical Trial Update: Safety of rFXIII in Patients Following First Time Myocardial Revascularization Requiring Cardiopulmonary Bypass [Phase 1]